CHP
KYNB

Cable Hill Partners’s Kyntra Bio KYNB Stock Holding History

Cable Hill Partners’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3
Closed -$4K – 319
2019
Q1 		$4K Hold
3
– – ﹤0.01% 653
2018
Q4 		$3K Hold
3
– – ﹤0.01% 654
2018
Q3 		$4K Hold
3
– – ﹤0.01% 609
2018
Q2 		$5K Buy
3
+1
+50% +$1.3K ﹤0.01% 650
2018
Q1 		$2K Hold
2
– – ﹤0.01% 819
2017
Q4 		$3K Sell
2
-4
-67% -$5.02K ﹤0.01% 818
2017
Q3 		$7K Buy
+6
New +$6.32K ﹤0.01% 670

Other funds holding KYNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Cable Hill Partners's KYNB Position: Q2 2019 in Review

Cable Hill Partners sold out of Kyntra Bio (KYNB) in Q2 2019, closing a stake of 3 shares — an estimated $4K sold.

Cable Hill Partners first reported a position in KYNB in Q3 2017 and held it in 7 quarters. The position peaked at $7K in Q3 2017. 190 funds tracked by Wall St. Rank hold KYNB as of Q2 2019.

  • Cable Hill Partners reported no remaining Kyntra Bio position as of Q2 2019 after selling out during the quarter.
  • Cable Hill Partners sold 3 Kyntra Bio shares in Q2 2019, an estimated $4K.
  • Cable Hill Partners first reported a position in Kyntra Bio in Q3 2017 and held it in 7 quarters.
  • Cable Hill Partners's Kyntra Bio position peaked at $7K in Q3 2017.
  • 190 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2019.

Based on Cable Hill Partners's 13F filing for Q2 2019, filed 6 Aug 2019.